Daré Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	2.81	10	0	0	0	0	0	0	0	0.08	Upgrade
Revenue Growth (YoY)	-71.92%	-	-	-	-	-	-	-	-	1233.33%	Upgrade
Gross Profit	2.81	10	0	0	0	0	0	0	0	0.08	Upgrade
Selling, General & Admin	12.11	11.24	8.35	6.55	5.27	4.66	2.7	0.16	11.22	8.59	Upgrade
Research & Development	21.54	30.04	30.62	20.77	8.55	6.41	0.98	0.07	25.95	11.77	Upgrade
Other Operating Expenses	0.1	0.1	0.1	0.08	0.53	5.81	7.49	0.4	0	0	Upgrade
Operating Expenses	33.75	41.39	39.07	27.4	14.34	16.88	11.18	0.63	37.17	20.36	Upgrade
Operating Income	-30.94	-31.39	-39.07	-27.4	-14.34	-16.88	-11.18	-0.63	-37.17	-20.28	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	0.04	2.43	1.08	Upgrade
Other Expense / Income	-0.78	-0.44	-0.37	-0	-0.08	-0.14	0.32	-	-0.01	1.98	Upgrade
Pretax Income	-30.16	-30.95	-38.7	-27.4	-14.26	-16.74	-11.5	-0.67	-39.59	-23.34	Upgrade
Net Income	-30.16	-30.95	-38.7	-27.4	-14.26	-16.74	-11.5	-0.67	-39.59	-23.34	Upgrade
Preferred Dividends	0	0	0	0.01	0.79	0	0	0	0	0	Upgrade
Net Income Common	-30.16	-30.95	-38.7	-27.41	-15.05	-16.74	-11.5	-0.67	-39.59	-23.34	Upgrade
Shares Outstanding (Basic)	87	85	61	30	16	11	3	1	3	1	Upgrade
Shares Outstanding (Diluted)	87	85	61	30	16	11	3	1	3	1	Upgrade
Shares Change	3.23%	38.29%	103.23%	93.15%	45.16%	232.04%	287.10%	-67.17%	74.80%	2025.95%	Upgrade
EPS (Basic)	-0.35	-0.37	-0.63	-0.91	-0.97	-1.57	-3.56	-0.81	-15.60	-16.00	Upgrade
EPS (Diluted)	-0.35	-0.37	-0.63	-0.91	-0.97	-1.57	-3.56	-0.81	-15.60	-16.00	Upgrade
Free Cash Flow	-39.49	-18.15	-28.78	-25.25	-13.32	-10.28	-2.54	-0.37	-32.17	-19.25	Upgrade
Free Cash Flow Per Share	-0.45	-0.21	-0.47	-0.84	-0.85	-0.96	-0.79	-0.45	-12.65	-13.23	Upgrade
Gross Margin	100.00%	100.00%	-	-	-	-	-	-	-	100.00%	Upgrade
Operating Margin	-1101.89%	-313.85%	-	-	-	-	-	-	-	-25348.75%	Upgrade
Profit Margin	-1074.17%	-309.48%	-	-	-	-	-	-	-	-29177.50%	Upgrade
Free Cash Flow Margin	-1406.26%	-181.51%	-	-	-	-	-	-	-	-24057.50%	Upgrade
EBITDA	-30.07	-30.9	-38.77	-27.52	-14.28	-16.73	-11.5	-0.63	-36.97	-22.13	Upgrade
EBITDA Margin	-1070.88%	-309.00%	-	-	-	-	-	-	-	-27666.25%	Upgrade
Depreciation & Amortization	0.09	0.05	-0.07	-0.12	-0.02	0.01	0	0	0.19	0.13	Upgrade
EBIT	-30.16	-30.95	-38.7	-27.4	-14.26	-16.74	-11.5	-0.63	-37.16	-22.26	Upgrade
EBIT Margin	-1074.17%	-309.48%	-	-	-	-	-	-	-	-27823.75%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).